Servier Pharmaceuticals

Servier Group was founded by Jacques Servier in 1954 in Orléans, France. In 2018, Servier Group established and began operations of Servier Pharmaceuticals in the United States. Servier Pharmaceuticals is committed to building a portfolio of innovative drugs to provide life-saving treatments for more than 100 million patients worldwide.Currently, Servier Pharmaceuticals has two oncology products on the market for acute lymphoblastic leukemia (ALL) and plans to expand into other therapeutic areas with unmet medical needs.